187 related articles for article (PubMed ID: 16260046)
1. Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors.
Costa T; Cotecchia S
Trends Pharmacol Sci; 2005 Dec; 26(12):618-24. PubMed ID: 16260046
[TBL] [Abstract][Full Text] [Related]
2. Efficacy as a vector: the relative prevalence and paucity of inverse agonism.
Kenakin T
Mol Pharmacol; 2004 Jan; 65(1):2-11. PubMed ID: 14722230
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.
Milligan G
Mol Pharmacol; 2003 Dec; 64(6):1271-6. PubMed ID: 14645655
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
Bond RA; Ijzerman AP
Trends Pharmacol Sci; 2006 Feb; 27(2):92-6. PubMed ID: 16406086
[TBL] [Abstract][Full Text] [Related]
5. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
Prather PL
Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
[TBL] [Abstract][Full Text] [Related]
6. Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing?
Greasley PJ; Clapham JC
Eur J Pharmacol; 2006 Dec; 553(1-3):1-9. PubMed ID: 17081515
[TBL] [Abstract][Full Text] [Related]
7. The evasive nature of drug efficacy: implications for drug discovery.
Galandrin S; Oligny-Longpré G; Bouvier M
Trends Pharmacol Sci; 2007 Aug; 28(8):423-30. PubMed ID: 17659355
[TBL] [Abstract][Full Text] [Related]
8. Functional selectivity through protean and biased agonism: who steers the ship?
Kenakin T
Mol Pharmacol; 2007 Dec; 72(6):1393-401. PubMed ID: 17901198
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of inverse agonism in a G protein-coupled receptor.
Vilardaga JP; Steinmeyer R; Harms GS; Lohse MJ
Nat Chem Biol; 2005 Jun; 1(1):25-8. PubMed ID: 16407989
[TBL] [Abstract][Full Text] [Related]
11. When simple agonism is not enough: emerging modalities of GPCR ligands.
Smith NJ; Bennett KA; Milligan G
Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
[TBL] [Abstract][Full Text] [Related]
12. Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling.
Piñeyro G
Cell Signal; 2009 Feb; 21(2):179-85. PubMed ID: 18790047
[TBL] [Abstract][Full Text] [Related]
13. Inverse agonism: more than reverting constitutively active receptor signaling.
Dupré DJ; Rola-Pleszczynski M; Stanková J
Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
[TBL] [Abstract][Full Text] [Related]
14. G-protein-coupled receptor pharmacology: examining the edges between theory and proof.
Gilchrist A; Blackmer T
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):446-51. PubMed ID: 17659486
[TBL] [Abstract][Full Text] [Related]
15. New concepts in drug discovery: collateral efficacy and permissive antagonism.
Kenakin T
Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activity and inverse agonism at the alpha1adrenoceptors.
Cotecchia S
Biochem Pharmacol; 2007 Apr; 73(8):1076-83. PubMed ID: 17125741
[TBL] [Abstract][Full Text] [Related]
17. G protein coupled receptors as allosteric proteins and the role of allosteric modulators.
Kenakin T
J Recept Signal Transduct Res; 2010 Oct; 30(5):313-21. PubMed ID: 20858023
[TBL] [Abstract][Full Text] [Related]
18. [G-protein-coupled receptors plasticity and signalling].
Galés C
Med Sci (Paris); 2012 Oct; 28(10):883-5. PubMed ID: 23067421
[TBL] [Abstract][Full Text] [Related]
19. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology.
Nelson CP; Challiss RA
Biochem Pharmacol; 2007 Mar; 73(6):737-51. PubMed ID: 17046719
[TBL] [Abstract][Full Text] [Related]
20. Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant?
Parra S; Bond RA
Curr Opin Pharmacol; 2007 Apr; 7(2):146-50. PubMed ID: 17284360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
